In Vitro-In Vivo Relationship in Mini-Scale-Enabling Formulations of Corallopyronin A
In vivo studies in mice provide a valuable model to test novel active pharmaceutical ingredients due to their low material need and the fact that mice are frequently used as a species for early efficacy models. However, preclinical in vitro evaluations of formulation principles in mice are still lac...
Saved in:
Main Authors: | Tim Becker (Author), Anna K. Krome (Author), Sahel Vahdati (Author), Andrea Schiefer (Author), Kenneth Pfarr (Author), Alexandra Ehrens (Author), Tilman Aden (Author), Miriam Grosse (Author), Rolf Jansen (Author), Silke Alt (Author), Thomas Hesterkamp (Author), Marc Stadler (Author), Marc P. Hübner (Author), Stefan Kehraus (Author), Gabriele M. König (Author), Achim Hoerauf (Author), Karl G. Wagner (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2022-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Pharmacokinetics and Pharmacodynamics (PK/PD) of Corallopyronin A against Methicillin-Resistant <i>Staphylococcus aureus</i>
by: Katharina Rox, et al.
Published: (2022) -
Corallopyronin A for short-course anti-wolbachial, macrofilaricidal treatment of filarial infections.
by: Andrea Schiefer, et al.
Published: (2020) -
The RNA Polymerase Inhibitor Corallopyronin A Has a Lower Frequency of Resistance Than Rifampicin in <i>Staphylococcus aureus</i>
by: Jan Balansky, et al.
Published: (2022) -
Solubility and Stability Enhanced Oral Formulations for the Anti-Infective Corallopyronin A
by: Anna K. Krome, et al.
Published: (2020) -
Mesoporous Silica as an Alternative Vehicle to Overcome Solubility Limitations
by: Tim Becker, et al.
Published: (2024)